SCHEMBL6586909

SCHEMBL6586909

C[C@@H](O)CNC(=O)N1CC(Oc2cccc(Cl)c2)C1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 5/20 0.44
CYP2C9 P11712 1/20 0.43
CYP2J2 P51589 1/20 0.43
ACACB O00763 2/20 0.43
OGG1 O15527 1/20 0.41
CHRNA7 P36544 1/20 0.40
SCN9A Q15858 1/20 0.40
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
SLC6A4 P31645 2/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
PDE9A O76083 2/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
DPP4 P27487 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6586914 1.00 EPHX2 (0.44) EPHX2CYP2C9CYP2J2ACACBOGG1
SCHEMBL6584945 0.88 CHRNA7 (0.41) EPHX2CYP2C9CYP2J2ACACBCHRNA7
SCHEMBL6584937 0.88 CHRNA7 (0.41) EPHX2CYP2C9CYP2J2ACACBCHRNA7
SCHEMBL6585234 0.86 EPHX2 (0.47) EPHX2CYP2C9CYP2J2ACACBCHRNA7
SCHEMBL6586275 0.86 EPHX2 (0.47) EPHX2CYP2C9CYP2J2ACACBCHRNA7
SCHEMBL6585239 0.86 EPHX2 (0.47) EPHX2CYP2C9CYP2J2ACACBCHRNA7
SCHEMBL6585993 0.85 CCR3 (0.45) EPHX2CHRNA7SLC6A4SLC6A2SLC6A3
SCHEMBL6585997 0.85 CCR3 (0.45) EPHX2CHRNA7SLC6A4SLC6A2SLC6A3
SCHEMBL6584876 0.84 KDM4E (0.49) EPHX2ACACBSCN9ASLC6A4SLC6A2
SCHEMBL9450842 0.83 EPHX2 (0.50) EPHX2CYP2C9CYP2J2OGG1SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1049671-B1 AZETIDINECARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS VERNALIS RES LTD (GB) 2004-04-21 EP claimed
US-6514961-B1 Such as anxiety and all forms of epilepsy, particularly in humans VERNALIS RESEARCH LIMITED (GB) 2003-02-04 US claimed